Ari Melnick
Impact in
- Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Cancer Research top 0.2%
Papers in
-
- Epigenetics and DNA Methylation 108
- Cancer-related gene regulation 53
- Histone Deacetylase Inhibitors Research 36
- Protein Degradation and Inhibitors 36
- Hematology 108
- Acute Myeloid Leukemia Research 83
- Co-authors
- María E. Figueroa (56 shared papers)Jonathan D. Licht (26 shared papers)Christopher E. Mason (29 shared papers)Francine E. Garrett-Bakelman (23 shared papers)José M. Polo (26 shared papers)Leandro Cerchietti (63 shared papers)Sheng Li (7 shared papers)Rita Shaknovich (39 shared papers)
- Journals
- Blood (133 papers)Cancer Research (15 papers)Cell Reports (13 papers)Cancer Cell (9 papers)Journal of Clinical Investigation (8 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Ari Melnick
341 papers receiving 24.1k citations
Ari Melnick's Hit Papers
Peers
Comparison fields: 5 of 160
- Hematology 4.6k
- Cancer Research 3.8k
- Genetics 2.7k
- Molecular Biology 15.9k
- Immunology 3.7k
Countries citing papers authored by Ari Melnick
This map shows the geographic impact of Ari Melnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Melnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Melnick more than expected).
Fields of papers citing papers by Ari Melnick
This network shows the impact of papers produced by Ari Melnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Melnick. The network helps show where Ari Melnick may publish in the future.
Co-authors
The 25 scholars most cited alongside Ari Melnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 359 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IDH mutation impairs histone demethylation and results in a block to cell differentiation Hit paper breakdown → | 2012 | 1465 |
| 2 | methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles Hit paper breakdown → | 2012 | 1430 |
| 3 | The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells Hit paper breakdown → | 2017 | 947 |
| 4 | Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Hit paper breakdown → | 2010 | 897 |
| 5 | Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia Hit paper breakdown → | 1999 | 822 |
| 6 | A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells Hit paper breakdown → | 2012 | 633 |
| 7 | Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis Hit paper breakdown → | 2012 | 584 |
| 8 | DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia Hit paper breakdown → | 2010 | 581 |
| 9 | 2013 | 385 | |
| 10 | 2006 | 288 | |
| 11 | 2009 | 252 | |
| 12 | 2009 | 234 | |
| 13 | 2009 | 231 | |
| 14 | 2004 | 230 | |
| 15 | 2010 | 227 | |
| 16 | 2010 | 223 | |
| 17 | 2003 | 217 | |
| 18 | 2012 | 205 | |
| 19 | 2007 | 204 | |
| 20 | 2014 | 199 |
About Ari Melnick
Ari Melnick is a scholar working on Molecular Biology, Hematology, Immunology, Oncology and Pathology and Forensic Medicine, having authored 359 papers that have together received 24.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (108 papers), Acute Myeloid Leukemia Research (83 papers), Lymphoma Diagnosis and Treatment (61 papers), Cancer-related gene regulation (53 papers), Immune Cell Function and Interaction (51 papers), CAR-T cell therapy research (41 papers), Histone Deacetylase Inhibitors Research (36 papers) and Protein Degradation and Inhibitors (36 papers). The work is most often cited by research in Hematology (4.6k citations), Cancer Research (3.8k citations), Genetics (2.7k citations), Molecular Biology (15.9k citations) and Immunology (3.7k citations). Ari Melnick has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include María E. Figueroa, Jonathan D. Licht, Christopher E. Mason, Francine E. Garrett-Bakelman, José M. Polo, Leandro Cerchietti, Sheng Li, Rita Shaknovich, Matthías Kormáksson and Katerina Hatzi. Their work appears in journals such as Blood, Cancer Research, Cell Reports, Cancer Cell and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.